# Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)

> **NCT06795659** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 4 (actual)

## Conditions studied

- Post Traumatic Stress Disorder PTSD

## Interventions

- **DRUG:** Esketamine (Intranasal Spray)
- **BEHAVIORAL:** Massed Prolonged Exposure (PE)

## Key facts

- **NCT ID:** NCT06795659
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-09
- **Primary completion:** 2026-01-16
- **Final completion:** 2026-01-16
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06795659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06795659, "Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06795659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*